We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Analysis

Sham Petition Suits Are Piercing Big Pharma's Antitrust Shield

Law360 (September 25, 2018, 7:54 PM EDT) -- A long-standing U.S. Supreme Court doctrine shielding companies that petition the U.S. Food and Drug Administration from antitrust liability is proving increasingly unhelpful to brand-name drugmakers accused of delaying generic-drug rivals...
To view the full article, register now.

Related

Sections

Case Information

Case Title

Subscribers Only

Case Number

Subscribers Only

Court

Appellate - 3rd Circuit

Nature of Suit

3410 Antitrust

Date Filed

October 24, 2014


Case Title

Subscribers Only

Case Number

Subscribers Only

Court

Delaware

Nature of Suit

Anti-Trust

Judge

Subscribers Only

Date Filed

February 7, 2017


Case Title

Subscribers Only

Case Number

Subscribers Only

Court

Kansas

Nature of Suit

Personal Inj. Prod. Liability

Judge

Subscribers Only

Date Filed

August 4, 2017


Case Title

Subscribers Only

Case Number

Subscribers Only

Court

New York Eastern

Nature of Suit

Anti-Trust

Judge

Subscribers Only

Date Filed

January 31, 2018

Law Firms

Companies

Government Agencies

Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.